Taysha Gene Therapies, Inc. - TSHA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G | Vestal Point Capital, LP | 5.0% | 13,750,000 | View |
| Feb 17, 2026 | SCHEDULE 13G | Ryan Wilder | 5.0% | 13,750,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 8.3% | 23,407,133 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Roderick Wong | 8.3% | 23,407,133 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 4.9% | 13,528,366 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 4.9% | 13,528,366 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | RA Capital Management, L.P. | 9.9% | 27,662,481 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Peter Kolchinsky | 9.9% | 27,662,481 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Rajeev Shah | 9.9% | 27,662,481 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 9.9% | 27,662,481 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Octagon Capital Advisors LP | 3.3% | 9,067,500 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Octagon Investments Master Fund | 3.3% | 9,067,500 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ting Jia | 3.3% | 9,067,500 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.